Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,417
datasets available to search
ShareScore release 0.9.0
Dataset results
1,417 results for “triple negative breast cancer”
Effect of Bevacizumab in Metastatic Triple Negative Breast Cancer
ClinicalTrials.gov study NCT03577743. IPD Sharing: NO. Countries: 1. Publications: 4.
Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer
ClinicalTrials.gov study NCT02876107. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Olaparib and Durvalumab in Treating Participants With Metastatic Triple Negative Breast Cancer
ClinicalTrials.gov study NCT03544125. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Pembrolizumab (MK-3475) Monotherapy for Metastatic Triple-Negative Breast Cancer (MK-3475-086/KEYNOTE-086)
ClinicalTrials.gov study NCT02447003. IPD Sharing: YES. Countries: 0. Publications: 5.
Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse in Triple Negative Breast Cancer Patients
ClinicalTrials.gov study NCT04438681. IPD Sharing: Not stated. Countries: 1. Publications: 2.
99mTc-MY6349 SPECT/CT Imaging in Trop2-positive Triple-negative Breast Cancer
ClinicalTrials.gov study NCT06104085. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients
ClinicalTrials.gov study NCT03671044. IPD Sharing: Not stated. Countries: 2. Publications: 1.
MUC1 Vaccine for Triple-negative Breast Cancer
ClinicalTrials.gov study NCT00986609. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Comparative Efficacy of Xiaopi Granules and Decoction in Triple-negative Breast Cancer: a Randomized Controlled Trial
ClinicalTrials.gov study NCT06154109. IPD Sharing: NO. Countries: 0. Publications: 9.
Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients
ClinicalTrials.gov study NCT02221999. IPD Sharing: Not stated. Countries: 1. Publications: 4.
ABX Plus Cisplatin Versus Gemcitabine Plus Cisplatin in Triple Negative Breast Cancer (TNBC)
ClinicalTrials.gov study NCT02546934. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Neoadjuvant Chemotherapy Response in Metaplastic Carcinoma of Triple Negative Breast Cancer
ClinicalTrials.gov study NCT04549584. IPD Sharing: NO. Countries: 1. Publications: 3.
Omission of SLNB in Triple-negative and HER2-positive Breast Cancer Patients with RCR and PCR in the Breast After NAST
ClinicalTrials.gov study NCT04101851. IPD Sharing: NO. Countries: 4. Publications: 1.
Investigation of Gene Mutations in Patients With Triple-negative and Patients With HER2+ Breast Cancer Adenocarcinoma
ClinicalTrials.gov study NCT04365790. IPD Sharing: NO. Countries: 1. Publications: 7.
Study of Safety and Efficacy of Durvalumab in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer Patients
ClinicalTrials.gov study NCT02628132. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Safety of TT-00420 (Tinengotinib) Monotherapy in Patients With Advanced Solid Tumors and Triple Negative Breast Cancer
ClinicalTrials.gov study NCT03654547. IPD Sharing: NO. Countries: 2. Publications: 1.
Calorie Restriction With or Without Metformin in Triple Negative Breast Cancer
ClinicalTrials.gov study NCT04248998. IPD Sharing: NO. Countries: 1. Publications: 41.
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
ClinicalTrials.gov study NCT03281954. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT02455141. IPD Sharing: Not stated. Countries: 1. Publications: 6.
Dinaciclib and Epirubicin Hydrochloride in Treating Patients With Metastatic Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT01624441. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.